Navigation Links
Essilor's First-Half 2008 Results
Date:8/27/2008

ffective

tax rate compared with a 32.0% rate for first-half 2007. The

improvement was driven by a lower average tax rate in Europe and

business growth in Asia, where the rate is below the Company average.

- The share of profit from associates-VisionWeb, Sperian

Protection and Transitions-which amounted to EUR14.7 million, versus

EUR15.3 million in first-half 2007. Earnings from Transitions declined

slightly to EUR9.6 million, from EUR10.1 million for the prior-year

period, because of a strongly negative currency effect and the

concentration of marketing costs in the first half related to the

launch of the sixth generation of variable-tint lenses in North

America.

Profit attributable to equity holders of the parent was 9.0% higher, at EUR198.3 million. Earnings per share rose by 8.1% to EUR0.96.

Inventories and work in progress

Inventories amounted to EUR400 million at June 30, 2008, compared with 394 million at December 31, 2007, a 1.5% increase. The like-for-like increase was 4.3%, below the rate of revenue growth.

Investments

Capital expenditure net of divestments totaled EUR95 million or 6.2% of consolidated revenue. Financial investments net of disposals amounted to EUR140.2 million. Of this amount, acquisitions accounted for EUR75.7 million, while buybacks of Essilor shares accounted for EUR64.5 million.
Cash Flow Statement

EUR millions

Net cash from operations 275 Capital expenditure 95

net of the proceeds

from asset sales

Proceeds from employee share 22 Change in WCR and 92

issue provisions

Net decrease in cash and 150 Dividends 129

cash equivalents

Effect of changes in 9 Financial investments 140

exchange rates and i
'/>"/>

SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Biopure Announces 2008 Third Quarter Financial Results
2. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
3. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
4. Arpida Reports Interim Results for Six Months to 30 June 2008
5. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
6. Rosetta Genomics Reports Second Quarter 2008 Financial Results
7. VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
8. Arno Therapeutics Announces Second Quarter 2008 Financial Results
9. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
10. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
11. Yongye Biotechnology International Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , 27. März 2015  Peter ... in Biomedical Science für seine bahnbrechende Arbeit ... zwischen Zellkompartimenten transportiert werden, sowie für die ... zur Reaktion auf Stress nutzen, der mit ... Walter ist Professor für Biochemie an der ...
(Date:3/27/2015)... , March 27, 2015   SurePure, Inc ... photopurification, announced today that the Company has completed ... continued trading of SurePure ("SURP") securities on OTCQB, ... for entrepreneurial and development stage companies. ... standards and eligibility requirements designed to improve marketplace ...
(Date:3/27/2015)... March 27, 2015 Working in collaboration ... in London , Richmond Pharmacology is the ... Phase 3 study for an investigational RNAi therapeutic being developed ... affecting the nerves and heart. Read press ... Based at St Georges University of ...
(Date:3/27/2015)... 27, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , today ... ended December 31, 2014.  The Company ... per share, for the three months ended December 31, ...
Breaking Biology Technology:Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4SurePure Completes Verification and Approved for Trading on the OTCQB Marketplace 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6
... smaller and more complex every year. It turns out that ... to small devices, such as cell phones, hitting the floor. ... when dropped? , A team of Clemson University researchers, led ... to make beds of tiny, shock-absorbing carbon springs which possibly ...
... N.J., Aug. 13 At the upcoming Medical,Grade ... Team,Leader, will present "Silicone Elastomer Gels: New Soft ... in Philadelphia, September 16-17., According to Dr. ... that provide differentiated performance features for wound care,scar ...
... MS, - Milestone triggers $10 million payment ... Aug. 13 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX:,MS), ... sclerosis (MS), today,announced that the independent Drug Safety ... the scheduled interim analysis of efficacy,and safety and ...
Cached Biology Technology:Clemson scientists put a (nano) spring in their step 2Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference 2BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis 2BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis 3BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis 4
(Date:3/16/2015)... 16, 2015 Between 16 ... present groundbreaking innovations in biometric identification at the ... .      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ... is well at the forefront: the company,s all ... in Germany . BiometricGate is ...
(Date:3/12/2015)... VIEW, Calif. , March 12, 2015 /PRNewswire/ ... with Complimentary Registration here: http://bit.ly/1G7Os0L . SPEAKERS: ... Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... in order to compete in several different markets ... market is currently witnessing an uptrend. ...
(Date:3/10/2015)... March 10, 2015 Transforming How ... "Personalized Medicine in Human Space Flight" by ... J. Goodwin , Ph.D. was recently featured by Springer ... two years. Specifically, "Personalized Medicine in Human ... papers published in 2013 and 2014 from Springer in ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... WAYNE, Pa., Dec. 14 MODA Technology Partners, a ... and product testing for the Pharmaceutical industry, today announced ... generation mobile data acquisition platform. The latest release enables ... manufacturing processes. , MODA 3.0 includes the following ...
... team led by Yale University researchers has used nanosensors ... first time. Their findings, which appear December 13 in ... could dramatically simplify the way physicians test for biomarkers ... teamled by Mark Reed, Yale,s Harold Hodgkinson Professor of ...
... increases, growers are being challenged to bring consistently ... bottom line, orchard owners are experimenting with new ... labor costs. Hand thinning, a common practice ... is among the most labor-intensive of orchard practices, ...
Cached Biology News:MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Horizontal string trimmer reduces labor costs, increases peach size 2
...
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
2ndGen Predilute antibody for staining tissue sections. Optimized for use with Zymeds Histostain-PLUS, NBA, HistoST5050, and Cap-Plus IHC Kits.Labeling: ASR...
Reactivity: Human...
Biology Products: